Robert V. Cattani, M.D.; Decision and Order, 44197-44198 [2014-17892]
Download as PDF
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
then proposed that Registrant’s license
be revoked. Id. at 21. The MBC adopted
the proposed decision, which became
effective on November 22, 2013. GX 7.
In his letter waiving Registrant’s right
to a hearing, Registrant’s counsel
acknowledges that Registrant’s medical
certificate had been revoked by the
MBC. GX 8, at 2. The letter then states
that the state ALJ ‘‘specifically left open
the possibility of reinstatement of
[Registrant’s] medical certificate upon
satisfaction of Business and Professions
Code section 822.’’ Id. Continuing,
Registrant ‘‘respectfully requests the
Drug Enforcement Administration allow
the same remedy to remain available for
purposes of DEA certificate and
registration.’’ Id. The waiver letter also
contains a ‘‘prayer . . . for reservation
of rights. . . . If [Registrant’s] Medical
Certificate is reinstated, the next logical
progression would to [sic] apply for
reinstatement of his DEA Certificate.
[Registrant] humbly seeks this avenue to
remain available to him, should he
return to the practice of medicine.’’ Id.
at 2–3.
An internet search of the MBC’s
public record actions Web page reveals
that Registrant’s medical license
remains revoked.
Discussion
The Controlled Substances Act (CSA)
grants the Attorney General authority to
revoke a registration ‘‘upon a finding
that the registrant . . . has had his State
license or registration suspended [or]
revoked . . . and is no longer
authorized by State law to engage in the
. . . distribution [or] dispensing of
controlled substances.’’ 21 U.S.C.
824(a)(3). Moreover, DEA has long held
that a practitioner must be currently
authorized to handle controlled
substances in the ‘‘jurisdiction in which
[he] practices’’ in order to maintain a
DEA registration. See 21 U.S.C. 802(21)
(‘‘the term ‘practitioner’ means a . . .
physician . . . or other person licensed,
registered or otherwise permitted, by
. . . the jurisdiction in which he
practices . . . to distribute, dispense,
[or] administer . . . a controlled
substance in the course of professional
practice.’’); see also id. § 823(f) (‘‘The
Attorney General shall register
practitioners . . . if the applicant is
authorized to dispense . . . controlled
substances under the laws of the State
in which he practices.’’). As these
provisions make plain, possessing
authority under state law to dispense
controlled substances is an essential
condition for holding a DEA
registration. See David W. Wang, 72 FR
54297, 54298 (2007); Sheran Arden
Yeates, 71 FR 39130, 39131 (2006);
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
Dominick A. Ricci, 58 FR 51104, 51105
(1993); Bobby Watts, 53 FR 11919,
11920 (1988).
Here, the evidence shows that
Respondent’s medical license has been
revoked and that he no longer holds
authority under California law to
dispense controlled substances.
Registrant is therefore not entitled to
maintain his DEA registration. See 21
U.S.C. 802(21), 823(f), and 824(a)(3).
Accordingly, Registrant’s registration
will be revoked.1
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b) and 0.104, I order
that DEA Certificate of Registration
BS4003795, issued to Franklyn
Seabrooks, M.D., be, and it hereby is,
revoked. I further order that any
pending application of Franklyn
Seabrooks, M.D., to renew or modify his
registration, be, and it hereby is, denied.
This Order is effective August 29, 2014.
Dated: July 22, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014–17893 Filed 7–29–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Robert V. Cattani, M.D.; Decision and
Order
On February 19, 2014, the Deputy
Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration, issued an Order to
Show Cause to Robert V. Cattani, M.D.
(hereinafter, Registrant, of Staten Island,
New York. The Show Cause Order
proposed the revocation of Registrant’s
DEA Certificate of Registration
AC6553437, which authorizes him to
dispense controlled substances in
schedules II through V as a practitioner,
on the ground that he does not possess
‘‘authority to practice medicine or
handle controlled substances in the
State of New York, the State in which
[he is] registered.’’ Show Cause Order at
1.
The Show Cause Order alleged that
Registrant is registered as a practitioner
in schedules II through V at the
registered location of 450 Slosson
Avenue, Staten Island, New York and
that his registration does not expire
until August 31, 2014. Id. The Show
Cause Order then alleged that on
1 In the event the MBC reinstates Registrant’s
Physician’s and Surgeon’s Certificate, he may apply
for a new DEA Certificate of Registration.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
44197
November 11, 2011, the New York State
Department of Health, State Board for
Professional Medical Conduct had
summarily suspended Registrant’s
medical license, and that following a
hearing, the Board revoked his medical
license effective September 10, 2012. Id.
The Show Cause Order further alleged
that on April 11, 2013, the New York
State Professional Medical Conduct
Administrative Review Board denied
Registrant’s appeal of the Board’s order,
and that order remains in effect. Id.
Based on Registrant’s ‘‘lack of authority
to handle controlled substances in the
State of New York,’’ the Show Cause
Order thus asserted that his registration
must be revoked. Id. at 2 (citing 21
U.S.C. 802(21), 823(f), and 824(a)(3)).
Finally, the Show Cause Order notified
Registrant that he had the right to
request a hearing on the allegations or
to submit a written statement in lieu of
a hearing, the procedures for electing
either option, and the consequence of
failing to electing either option. Id.
On March 4, 2014, two DEA Diversion
Investigators (DIs) went to a residence
located in Lloyd Harbor, New York,
which they believed was Registrant’s
residence. GX 2, at 3. Beforehand, they
went to the post office which services
this address and confirmed that
Registrant was still receiving mail at this
address. Id. The DIs then went to the
residence, where they rang the bell and
knocked on the door. Id. While the DIs
heard a voice inside, no one answered
the door. The DI then attached the
envelope which contained the Show
Cause Order to the front door. Id.
As the DIs were walking away, a male
opened the door from inside and
retrieved the envelope; the DI asked the
person if he was Registrant. Id. While
the person said ‘‘no’’ and slammed the
door, the DI recognized him as being
Registrant from photographs she had
previously seen. Id.
On leaving the residence, the DI also
noted the license plate number of a
vehicle parked in the driveway. Id. The
next day she determined that the car
had been rented by Registrant. Id.
Based on the above, I find that
Registrant has been served with the
Order to Show Cause. Based on the
Government’s representation that since
the date of service, neither Registrant,
nor any person purporting to represent
him, ‘‘has requested a hearing or
otherwise corresponded with DEA’’
regarding the Show Cause Order, and
finding that more than thirty (30 days)
have no passed, I find that Registrant
has waived his right to request a hearing
or to submit a written statement in lieu
of a hearing. 21 CFR 1301.43(d). I
therefore issue this Decision and Final
E:\FR\FM\30JYN1.SGM
30JYN1
44198
Federal Register / Vol. 79, No. 146 / Wednesday, July 30, 2014 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Order based on the record submitted by
the Government. 21 CFR 1301.43(e). I
make the following findings.
Findings
Registrant is the holder of DEA
Certificate of Registration AC6553437,
which authorizes him to dispense
controlled substances in schedules II
through V as a practitioner at the
registered address of 450 Slosson
Avenue, Staten Island, New York. GX
2A. His registration does not expire
until August 31, 2014. Id.
On November 2, 2011, the New York
Bureau of Professional Medical Conduct
issued a Statement of Charges to
Registrant, alleging, inter alia, that he
had committed gross negligence in
performing plastic surgery on five
patients, that he ‘‘practice[ed] the
profession of medicine with negligence’’
and ‘‘with incompetence on more than
one occasion,’’ and that he failed to
maintain accurate records regarding his
treatment of four of the patients. GX 2B.
On December 6, 2011, the
Commissioner of the New York
Department of Health concluded that
Registrant’s ‘‘continued practice of
medicine . . . constitutes an imminent
danger to the health of the people of this
state’’ and ordered Registrant to
‘‘immediately’’ cease the practice of
medicine. GX 2C.
Thereafter, a Hearing Committee of
the State Board conducted a hearing. On
September 10, 2012, the Committee
issued its Determination and Order in
which it found most of the charges
proved and determined that ‘‘the only
way to ensure the safety of the public is
to revoke [Registrant’s] medical
license.’’ GX 2I, at 42. The Committee
thus ordered the revocation of
Registrant’s medical license, effective
upon service of the order. Id. at 43.
Registrant then sought review from
the New York Department of Health
Administrative Review Board (ARB). GX
2J. On or about April 4, 2013, the ARB
issued its Determination and Order,
affirming the Hearing Committee’s
determinations that Registrant
‘‘committed professional misconduct’’
and to revoke his medical license. Id. at
9. A search conducted on the New York
State Office of the Professions online
verification page establishes that
Registrant’s medical license remains
revoked.
Discussion
The Controlled Substances Act (CSA)
grants the Attorney General authority to
revoke a registration ‘‘upon a finding
that the registrant . . . has had his State
license or registration suspended [or]
revoked . . . and is no longer
VerDate Mar<15>2010
16:48 Jul 29, 2014
Jkt 232001
authorized by State law to engage in the
. . . distribution [or] dispensing of
controlled substances.’’ 21 U.S.C.
824(a)(3). Moreover, DEA has long held
that a practitioner must be currently
authorized to handle controlled
substances in the ‘‘jurisdiction in which
[he] practices’’ in order to maintain a
DEA registration. See 21 U.S.C. 802(21)
(‘‘the term ‘practitioner’ means a . . .
physician . . . or other person licensed,
registered or otherwise permitted, by
. . . the jurisdiction in which he
practices . . . to distribute, dispense,
[or] administer . . . a controlled
substance in the course of professional
practice.’’); see also id. § 823(f) (‘‘The
Attorney General shall register
practitioners . . . if the applicant is
authorized to dispense . . . controlled
substances under the laws of the State
in which he practices.’’). As these
provisions make plain, possessing
authority under state law to dispense
controlled substances is an essential
condition for holding a DEA
registration. See David W. Wang, 72 FR
54297, 54298 (2007); Sheran Arden
Yeates, 71 FR 39130, 39131 (2006);
Dominick A. Ricci, 58 FR 51104, 51105
(1993); Bobby Watts, 53 FR 11919,
11920 (1988).
Here, the evidence shows that
Respondent’s medical license has been
revoked and that he no longer holds
authority under New York law to
dispense controlled substances.
Registrant is therefore not entitled to
maintain his DEA registration. See 21
U.S.C. 802(21), 823(f), and 824(a)(3).
Accordingly, Registrant’s registration
will be revoked.
Order
Pursuant to the authority vested in me
by 21 U.S.C. 823(f) and 824(a), as well
as 28 CFR 0.100(b) and 0.104, I order
that DEA Certificate of Registration
AC6553437, issued to Robert V. Cattani,
M.D., be, and it hereby is, revoked. I
further order that any pending
application of Robert V. Cattani, M.D.,
to renew or modify his registration, be,
and it hereby is, denied. This Order is
effective August 29, 2014.
Dated: July 22, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014–17892 Filed 7–29–14; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
DEPARTMENT OF LABOR
Office of the Secretary
Agency Information Collection
Activities; Submission for OMB
Review; Comment Request;
Nondiscrimination Compliance
Information Reporting Under the
Workforce Investment Act of 1998
ACTION:
Notice.
On July 31, 2014, the
Department of Labor (DOL) will submit
the Office of the Assistant Secretary for
Administration and Management
(OASAM) sponsored information
collection request (ICR) revision titled,
‘‘Nondiscrimination Compliance
Information Reporting Under the
Workforce Investment Act of 1998,’’ to
the Office of Management and Budget
(OMB) for review and approval for use
in accordance with the Paperwork
Reduction Act (PRA) of 1995 (44 U.S.C.
3501 et seq.). Public comments on the
ICR are invited.
DATES: The OMB will consider all
written comments that agency receives
on or before September 2, 2014.
ADDRESSES: A copy of this ICR with
applicable supporting documentation;
including a description of the likely
respondents, proposed frequency of
response, and estimated total burden
may be obtained free of charge from the
RegInfo.gov Web site at https://www.
reginfo.gov/public/do/PRAViewICR?ref_
nbr=201404-1225-001 (this link will
only become active on August 1, 2014)
or by contacting Michel Smyth by
telephone at 202–693–4129, TTY 202–
693–8064 (these are not toll-free
numbers) or sending an email to DOL_
PRA_PUBLIC@dol.gov.
Submit comments about this request
by mail or courier to the Office of
Information and Regulatory Affairs,
Attn: OMB Desk Officer for DOL–DM,
Office of Management and Budget,
Room 10235, 725 17th Street NW.,
Washington, DC 20503; by Fax: 202–
395–6881 (this is not a toll-free
number); or by email: OIRA_
submission@omb.eop.gov. Commenters
are encouraged, but not required, to
send a courtesy copy of any comments
by mail or courier to the U.S.
Department of Labor-OASAM, Office of
the Chief Information Officer, Attn:
Departmental Information Compliance
Management Program, Room N1301,
200 Constitution Avenue NW.,
Washington, DC 20210; or by email:
DOL_PRA_PUBLIC@dol.gov.
FOR FURTHER INFORMATION CONTACT:
Contact Michel Smyth by telephone at
202–693–4129, TTY 202–693–8064,
SUMMARY:
E:\FR\FM\30JYN1.SGM
30JYN1
Agencies
[Federal Register Volume 79, Number 146 (Wednesday, July 30, 2014)]
[Notices]
[Pages 44197-44198]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-17892]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Robert V. Cattani, M.D.; Decision and Order
On February 19, 2014, the Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement Administration, issued an Order to
Show Cause to Robert V. Cattani, M.D. (hereinafter, Registrant, of
Staten Island, New York. The Show Cause Order proposed the revocation
of Registrant's DEA Certificate of Registration AC6553437, which
authorizes him to dispense controlled substances in schedules II
through V as a practitioner, on the ground that he does not possess
``authority to practice medicine or handle controlled substances in the
State of New York, the State in which [he is] registered.'' Show Cause
Order at 1.
The Show Cause Order alleged that Registrant is registered as a
practitioner in schedules II through V at the registered location of
450 Slosson Avenue, Staten Island, New York and that his registration
does not expire until August 31, 2014. Id. The Show Cause Order then
alleged that on November 11, 2011, the New York State Department of
Health, State Board for Professional Medical Conduct had summarily
suspended Registrant's medical license, and that following a hearing,
the Board revoked his medical license effective September 10, 2012. Id.
The Show Cause Order further alleged that on April 11, 2013, the New
York State Professional Medical Conduct Administrative Review Board
denied Registrant's appeal of the Board's order, and that order remains
in effect. Id. Based on Registrant's ``lack of authority to handle
controlled substances in the State of New York,'' the Show Cause Order
thus asserted that his registration must be revoked. Id. at 2 (citing
21 U.S.C. 802(21), 823(f), and 824(a)(3)). Finally, the Show Cause
Order notified Registrant that he had the right to request a hearing on
the allegations or to submit a written statement in lieu of a hearing,
the procedures for electing either option, and the consequence of
failing to electing either option. Id.
On March 4, 2014, two DEA Diversion Investigators (DIs) went to a
residence located in Lloyd Harbor, New York, which they believed was
Registrant's residence. GX 2, at 3. Beforehand, they went to the post
office which services this address and confirmed that Registrant was
still receiving mail at this address. Id. The DIs then went to the
residence, where they rang the bell and knocked on the door. Id. While
the DIs heard a voice inside, no one answered the door. The DI then
attached the envelope which contained the Show Cause Order to the front
door. Id.
As the DIs were walking away, a male opened the door from inside
and retrieved the envelope; the DI asked the person if he was
Registrant. Id. While the person said ``no'' and slammed the door, the
DI recognized him as being Registrant from photographs she had
previously seen. Id.
On leaving the residence, the DI also noted the license plate
number of a vehicle parked in the driveway. Id. The next day she
determined that the car had been rented by Registrant. Id.
Based on the above, I find that Registrant has been served with the
Order to Show Cause. Based on the Government's representation that
since the date of service, neither Registrant, nor any person
purporting to represent him, ``has requested a hearing or otherwise
corresponded with DEA'' regarding the Show Cause Order, and finding
that more than thirty (30 days) have no passed, I find that Registrant
has waived his right to request a hearing or to submit a written
statement in lieu of a hearing. 21 CFR 1301.43(d). I therefore issue
this Decision and Final
[[Page 44198]]
Order based on the record submitted by the Government. 21 CFR
1301.43(e). I make the following findings.
Findings
Registrant is the holder of DEA Certificate of Registration
AC6553437, which authorizes him to dispense controlled substances in
schedules II through V as a practitioner at the registered address of
450 Slosson Avenue, Staten Island, New York. GX 2A. His registration
does not expire until August 31, 2014. Id.
On November 2, 2011, the New York Bureau of Professional Medical
Conduct issued a Statement of Charges to Registrant, alleging, inter
alia, that he had committed gross negligence in performing plastic
surgery on five patients, that he ``practice[ed] the profession of
medicine with negligence'' and ``with incompetence on more than one
occasion,'' and that he failed to maintain accurate records regarding
his treatment of four of the patients. GX 2B. On December 6, 2011, the
Commissioner of the New York Department of Health concluded that
Registrant's ``continued practice of medicine . . . constitutes an
imminent danger to the health of the people of this state'' and ordered
Registrant to ``immediately'' cease the practice of medicine. GX 2C.
Thereafter, a Hearing Committee of the State Board conducted a
hearing. On September 10, 2012, the Committee issued its Determination
and Order in which it found most of the charges proved and determined
that ``the only way to ensure the safety of the public is to revoke
[Registrant's] medical license.'' GX 2I, at 42. The Committee thus
ordered the revocation of Registrant's medical license, effective upon
service of the order. Id. at 43.
Registrant then sought review from the New York Department of
Health Administrative Review Board (ARB). GX 2J. On or about April 4,
2013, the ARB issued its Determination and Order, affirming the Hearing
Committee's determinations that Registrant ``committed professional
misconduct'' and to revoke his medical license. Id. at 9. A search
conducted on the New York State Office of the Professions online
verification page establishes that Registrant's medical license remains
revoked.
Discussion
The Controlled Substances Act (CSA) grants the Attorney General
authority to revoke a registration ``upon a finding that the registrant
. . . has had his State license or registration suspended [or] revoked
. . . and is no longer authorized by State law to engage in the . . .
distribution [or] dispensing of controlled substances.'' 21 U.S.C.
824(a)(3). Moreover, DEA has long held that a practitioner must be
currently authorized to handle controlled substances in the
``jurisdiction in which [he] practices'' in order to maintain a DEA
registration. See 21 U.S.C. 802(21) (``the term `practitioner' means a
. . . physician . . . or other person licensed, registered or otherwise
permitted, by . . . the jurisdiction in which he practices . . . to
distribute, dispense, [or] administer . . . a controlled substance in
the course of professional practice.''); see also id. Sec. 823(f)
(``The Attorney General shall register practitioners . . . if the
applicant is authorized to dispense . . . controlled substances under
the laws of the State in which he practices.''). As these provisions
make plain, possessing authority under state law to dispense controlled
substances is an essential condition for holding a DEA registration.
See David W. Wang, 72 FR 54297, 54298 (2007); Sheran Arden Yeates, 71
FR 39130, 39131 (2006); Dominick A. Ricci, 58 FR 51104, 51105 (1993);
Bobby Watts, 53 FR 11919, 11920 (1988).
Here, the evidence shows that Respondent's medical license has been
revoked and that he no longer holds authority under New York law to
dispense controlled substances. Registrant is therefore not entitled to
maintain his DEA registration. See 21 U.S.C. 802(21), 823(f), and
824(a)(3). Accordingly, Registrant's registration will be revoked.
Order
Pursuant to the authority vested in me by 21 U.S.C. 823(f) and
824(a), as well as 28 CFR 0.100(b) and 0.104, I order that DEA
Certificate of Registration AC6553437, issued to Robert V. Cattani,
M.D., be, and it hereby is, revoked. I further order that any pending
application of Robert V. Cattani, M.D., to renew or modify his
registration, be, and it hereby is, denied. This Order is effective
August 29, 2014.
Dated: July 22, 2014.
Thomas M. Harrigan,
Deputy Administrator.
[FR Doc. 2014-17892 Filed 7-29-14; 8:45 am]
BILLING CODE 4410-09-P